GlassScriptPhysician profile
William H Chapman
NPI 1588662514
$14,507.64
in general payments reported to CMS, 2019-2025
21 companies · $12K in 2025
The $12K reported for 2025 was more than what 95% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,065 · 2020: $123 · 2021: $126 · 2022: $208 · 2023: $260 · 2024: $195 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $10K · Food and Beverage: $1,034 · Travel and Lodging: $952.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $10,000.00 |
| Food and Beverage | $1,034.10 |
| Travel and Lodging | $951.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $11,230.57 | 2022-2025 | |
| Covidien LP | $1,869.70 | 2019-2020 | |
| Davol INC. | $304.71 | 2019-2025 | Phasix Mesh |
| Ethicon US, LLC | $225.60 | 2019-2025 | Contour, Enseal, Echelon Flex |
| Teleflex LLC | $217.34 | 2020-2025 | Titan Sgs Bailout Chuck |
| Takeda Pharmaceuticals U.S.A., INC. | $101.59 | 2022-2023 | Gattex |
| Phathom Pharmaceuticals, INC. | $87.89 | 2024-2025 | Voquezna |
| Avanos Medical | $66.34 | 2019 | |
| Currax Pharmaceuticals LLC | $46.94 | 2021 | |
| Novo Nordisk INC | $45.40 | 2019-2020 | |
| Baxter Healthcare | $42.74 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $42.34 | 2019-2023 | Bridion |
| Medtronic, INC. | $38.63 | 2025 | Transorb |
| Smith+Nephew, INC. | $34.76 | 2020-2024 | Stravix, Grafix Pl |
| Endo Pharmaceuticals INC. | $33.64 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intra-Sana Laboratories | $27.85 | 2021-2024 | Reltone 400 Mg, Glycate, Reltone 200 Mg |
| Endogastric Solutions, INC | $26.37 | 2022 | |
| Karl Storz Endoscopy-America | $19.32 | 2019 | |
| Integra Lifesciences Corporation | $17.81 | 2022 | |
| Coopersurgical, INC. | $16.88 | 2020 | |
| Tetraphase Pharmaceuticals, INC. | $11.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Chapman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.